CDR-H3 antibody design on RAbD MMSeqs2 50% identity split (test)
42.67AARDGENet
Evaluation results
| Method | Links | |||||
|---|---|---|---|---|---|---|
| DGENet2026.05 | 42.67 | 85.51 | 97.47 | 7.19 | 43.1 | |
| dyMEAN2026.05 | 41.84 | 83.92 | 97.18 | 8.1 | 40.7 | |
| GeoABMulti-Stage Pipeline=IgFold -> HDOCK -> CDR design model -> Rosetta2026.05 | 40.02 | 83.67 | 96.95 | 15.43 | 18.7 | |
| BoltzGen2026.05 | 39.07 | 83.72 | 96.75 | 2.69 | 47.3 | |
| MEANMulti-Stage Pipeline=IgFold -> HDOCK -> CDR design model -> Rosetta2026.05 | 37.38 | 82.52 | 96.88 | 17.3 | 16.2 | |
| DiffAbMulti-Stage Pipeline=IgFold -> HDOCK -> CDR design model -> Rosetta2026.05 | 35.31 | 82.81 | 96.95 | 23.24 | 15.8 | |
| HERN2026.05 | 32.65 | — | — | 9.15 | 29.4 | |
| RosettaAbMulti-Stage Pipeline=IgFold -> HDOCK -> CDR design model -> Rosetta2026.05 | 32.31 | 82.72 | 97.17 | 17.7 | 13.7 | |
| Proteo-R12026.05 | 10.75 | 96.93 | 98.16 | 2.46 | 80.1 |